Moreover, other receptors such as SSTR, GRPR, and Y1R have been described to be also overexpressed in breast cancer, and radiotracers targeting them are used ongoing in preclinical and in-first-human clinical studies. The gene discussed is GRPR; the disease is breast cancer.